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SUMMARY
In this study, we sought to determine the mechanism of early sex reversal in a teleost
by applying 4 hr feminization treatments to XY (17a-ethynylestradiol 2000mg L1)
and YY (6500mg L1) Nile tilapia embryos on the first day post-fertilization (dpf). We
then searched for changes in the expression profiles of some sex-differentiating
genes in the brain (cyp19a1b, foxl2, and amh) and in sex steroids (testosterone,
17b-estradiol, and 11-ketotestosterone) concentrations during embryogenesis and
gonad differentiation. No sex reversal was observed in YY individuals, whereas sex-
reversal rates in XY progeny ranged from 060%. These results, together with the
clearance profile of 17a-ethynylestradiol, confirmed the existence of an early sensi-
tive period for sex determination that encompasses embryonic and larval develop-
ment and is active prior to any sign of gonad differentiation. Estrogen treatment
induced elevated expression of cyp19a1b and higher testosterone and 17b-estradiol
concentrations at 4 dpf in both XY and YY individuals. foxl2 and amhwere repressed
at 4 dpf and their expression levels were not different between treated and control
groups at 14 dpf, suggesting that foxl2 did not control cyp19a1b in the brains of tilapia
embryos. Increased cyp19a1bexpression in treated embryos could reflect early brain
sexualization, although this difference alone cannot account for the observed sex
reversal as the treatment was ineffective in YY individuals. The differential sensitivity
of XY and YY genotypes to embryonic induced-feminization suggests that a sex
determinant on the sex chromosomes, such as a Y repressor or an X activator, may
influence sex reversal during the first steps of tilapia embryogenesis.
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While the process of sex determination is relatively
conserved and relies on a single pathway in the majority
of mammals, fish utilize many different sex-determining
systems that exist along a continuum ranging from pure
genetic determination (chromosomal XY, ZW, or polygen-
ic) to environmental determination (Devlin and Nagahama,
2002). In fish with genetic sex determination, a master sex-
determining gene similar to the mammalian SRY (Sinclair
et al., 1990) was characterized in a few species: dmy in the
Abbreviations: 11KT, 11-ketotestosetrone; dpf, days post-fertilization; E2,
17b-estradiol; EE2, 17a-ethynylestradiol; hpf, hours post-fertilization; P#, pop-
ulation number; T, Testosterone.; amh, anti-Müllerian hormone; cyp19a1, cyto-
chrome P450 aromatase; foxl2, forkhead box l2 transcription factor
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medaka Oryzias latipes (Matsuda et al., 2002), gsdf in
Oryzias luzonensis (Myosho et al., 2012), amhy in the
Patagonian pejerrey Odontesthes hatchery (Hattori et al.,
2012),amhr2 inthetigerpufferfishTakifugurubripes(Kamiya
et al., 2012), and sdY in the rainbow trout Oncorhynchus
mykiss (Yano et al., 2012). Of the most-important genes
acting downstream of Sry analogs during sexual differentia-
tion, amh (anti-Müllerian hormone) is associated with testis
differentiationwhilefoxl2(forkheadboxl2transcriptionfactor)
and cyp19a1 (cytochrome P450 aromatase) are linked to
ovarian development (Siegfried, 2010).
The role of amh during male differentiation in fish is still
unclear as teleosts do not haveMüllerian ducts. The finding
of amhy, a duplicated gene on the Y chromosome of pejer-
rey, and its receptor amhr2 as sex determinants reflects the
importance of amh signaling in certain fish (Hattori et al.,
2012; Kamiya et al., 2012). In tilapia, higher expression of
amh is observed in the differentiating testis starting around
20 days post-fertilization (dpf) and remains at a higher level
(Ijiri et al., 2008; Poonlaphdecha et al., 2011). Its dimorphic
expressionappearsearly in thebrainofmales,at theonsetof
gonad differentiation (10 dpf), suggesting an additional role
in brain sexualization (Poonlaphdecha et al., 2011).
Foxl2, on the other hand, is expressed in a female-
specific manner in the developing gonads of mammals,
birds, reptiles (Loffler et al., 2003), and fish (Guiguen et al.,
2010). Inmedaka, foxl2 is up-regulated at the first stages of
ovarian differentiation (Nakamoto et al., 2006). In tilapia, its
sexually dimorphic expression was reported as early as 9
dpf, before any sign of histological differentiation (Ijiri et al.,
2008). An in vitro study in tilapia identified foxl2 as an
important regulator of cyp19a1 transcription (Wang et al.,
2007); indeed these two genes are co-expressed in the
differentiating ovaries of rainbow trout (Vizziano-Cantonnet
et al., 2011) and tilapia (Wang et al., 2007).
Aromatase, encoded by cyp19a1a for the gonad form
and cyp19a1b for the brain form (Tchoudakova and
Callard 1998;Kwonet al., 2001), is responsible for estrogen
synthesis, and therefore plays a key role in sexual steroido-
genesis and gonad differentiation in fish (see reviews by
Diotel et al., 2010 and Guiguen et al., 2010). For example,
administration of estrogens to genetic males during the sex
differentiation period induced feminization of the gonads in
different species (Piferrer, 2001; Devlin and Nagahama,
2002) whereas treatment of fry with aromatase inhibitor
leads to masculinization in genetic females (Piferrer et al.,
1994; Afonso et al., 2001; Uchida et al., 2004). In rainbow
trout, cyp19a1a is up-regulated in the differentiating ovary
(von Schalburg et al., 2010) while in tilapia, expression of
cyp19a1a is up-regulated in female gonads from 9 dpf
onwards (D’Cotta et al., 2001; Ijiri et al., 2008; Poonlaph-
decha et al., 2013) and cyp19a1b is expressed in the brain
very early during ontogenesis, with no difference in expres-
sion profiles between sexes (Kwon et al., 2001). Although
the regulatory pathways of cypa19a1a and cyp19a1b have
their specificities, several authors suggested a possible
role for brain aromatase during brain and the gonad sexu-
alization in gonochoristic teleosts (Tsai et al., 2003;
Blazquez and Somoza, 2010; Le Page et al., 2010).
Nile tilapia has an XX/XY sex determination system that
can be overridden by exogenous steroids and high tempera-
ture (masculinizing effect above 328C) (Jalabert et al., 1974;
Baroiller et al., 1995, 1999).Thesensitiveperiodextends from
10 dpf (yolk-sac resorption) to 2530 dpf (formation of an
ovarian cavity or an intratesticular efferent duct) (Kobayashi
et al., 2008). Temperature-induced masculinization up-regu-
latesgonadexpressionofamhwhile repressingboth foxl2and
cyp19a1a expression as well as brain aromatase activity
(D’Cotta et al., 2001;Poonlaphdechaet al., 2013). In contrast,
estrogen-feminizing treatments up-regulate the expression of
bothcyp19a1 genes(Kobayashietal., 2003).Severalauthors
suggest that tilapiaalsopossessesasecondsensitivewindow
for sex determination, starting earlier in the embryonic phase.
Rosenstein andHulata (1992) attempted to feminizeMozam-
bique tilapia (O. mossambicus) using short estrogen (17b-
estradiol, progesterone, and flutamide) immersions of freshly
fertilizedeggs,but foundasimilarnumberof females in treated
and control groups. Rougeot et al. (2008a,b) showed that
thermal (>348C) and hormonal (17a-methyltestosterone,
17a-ethynylestradiol) treatments of embryos from 12hr
post-fertilization (hpf) to hatching induced, respectively, up
to 27% and 68% sex reversal inO. niloticus. They suggested
that early sex reversal treatments could act on the develop-
mentofprimordialgermcells,apparentasearlyas46hpf,and/
or somatic cells of the future gonad, or could influence brain
sexualization since the brain starts to differentiate at 31 hpf
(Morrison et al., 2001). A separate model that must be con-
sidered when interpreting how these early hormonal treat-
ments affect the sex-reversal mechanism is the possible
accumulation of hormones in the embryo and the vitellus,
which could lead to a delayed effect on embryogenesis such
that the hormones act directly on the developing gonad
(Piferrer and Donaldson, 1994). Characterization of the up-
take and clearance kinetics of 17a-ethynylestradiol (EE2)
administered to XY embryos following Rougeot’s procedure
showed that thewhole-bodyconcentrationofEE2at theonset
of gonad differentiation (10 dpf) was still very high (unpub-
lished data). Such delayed and prolonged hormonal supply
makes the identification of the period of hormone action and
target structure more difficult because of its ambiguity.
Thepresent study aimed to substantiate the existence of
a precocious sensitive period for sex reversal in Nile tilapia,
before the development of a gonadal primordium tissue,
and to explore themechanism(s) of sex reversal during this
period. We used short EE2 immersion treatments applied
at early embryonic stages to switch the phenotypic sex of
XY Nile tilapia. EE2 uptake and clearance were followed to
confirm early action of the exogenous hormone. Similar
treatmentswere applied toYYembryos to test the influence
of sexual genotype on sex-reversal sensitivity and on the
sex determination process. Sex-reversal mechanisms and
the hypothetical upstream role of the brain in the sex
determination process were investigated through the
measurements of the natural sexual steroids (testosterone,
17b-estradiol, and 11-ketotestosterone) and the expres-
sion of three main sex-differentiating genes (cyp19a1b,
amh, and foxl2) in the heads of treated embryos and
juveniles.
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RESULTS
Growth, Survival, and Sex-Ratios
Immersion treatments did not significantly affect the
growth of XY progeny during thewhole experimental period
(Fig. 1A). At 35 dpf, mean body weight of the three groups
were: 651 14mg for the group immersed at 1 dpf for 4 hr
in a dose of 2000mg EE2L1 (XY2000), 643 12mg for
the controls (XYC) immersed in ethanol 1:1000, and
649 15mg in the group immersed at 10 dpf for 4 hr in a
dose of 20mg EE2 L1 (XY20).
Growthwas very similar between the YY progeny aswell
(Fig. 1B), and immersion treatment did not affect the mean
bodyweight of the fish immersedat 1dpf for4 hr ina6500mg
EE2L1 solution (YY6500) or in the controls (YYC) im-
mersed at 1 dpf for 4 hr in ethanol 1:1000. In the group
fed from1040dpfwith500mgEE2kg1 food (YYD),which
served as a positive control for sex reversal, growth slowed
down after 19 days of treatment (28 dpf), resulting in a
significantly different mean body weight from both YYC
and YY6500 at 35 and 42 dpf. At the end of the experiment
(42dpf), themeanbodyweightswere respectively838 73,
864 80, and 433 64mg in YYC, YY6500, and YYD
progeny.
Survival rates in the XY progenies ranged from 1129%
in XYC, from 1634% in XY2000, and from 2450% in
XY20 groups (Table 1). Mean values were not significantly
different between XYC and XY2000, but the mean survival
rate was significantly higher in the XY20 group than in the
controls. In YY progeny, survival rates ranged from
3858% in YYC, from 2545% in YY6500, and from
5371% in YYD groups. The mean survival rate was
significantly higher in YYD compared to YYC and
YY6500 progeny.
Sex-ratio analysis revealed the expected absence of
females in the control groups (XYC and YYC) (Table 1).
In XY individuals, the efficiency of EE2 immersion treat-
ments differed between progeny. The proportion of females
in XY2000 ranged from 0.960.6%. Except for population 4
(P4) progeny, immersion treatment with a dose of 2000mg
L1 EE2 for 4 hr applied to 1 day-old embryos (XY2000)
significantly skewed the sex ratios toward females, with the
highest values for P2 (60.6%) and P5 (23.0%). Immersion
treatment of 10-days-old larvae at 20mgL1 EE2 resulted in
significant sex reversal only in these two progeny popula-
tions, at 8.6% and 4.0% of females for P2 and P5, respec-
tively, suggesting their increased sensitivity to steroid
feminization. InYYprogeny, however,EE2 immersion treat-
ment at 1 dpf did not lead to any significant sex reversal,
although these populations were clearly susceptible as die-
tary EE2 treatment (from 1040 dpf) achieved sex reversal
efficiencies of 83.7100%.
EE2 Uptake and Clearance
The EE2 used for the feminization treatment of XY
embryos (XY2000 group, 2000mg L1 at 1 dpf) passed
through the chorion and rapidly accumulated in the eggs,
resulting in a mean concentration of 18929 3565 ng g1
shortly after the immersion (Fig. 2A). This surge repre-
sented a 10-fold bioconcentration of the hormone com-
pared to the initial exposure dosage. Clearance kinetics
were rapid, as the concentration dropped to 4798 465 ng
g1 by 4 dpf and returned to a value (1.41 1.89 ng g1)
statistically similar to the control at 21 dpf (Fig. 2A and B).
The20mgL1 EE2dose used for the 4 hr treatment at 10
dpf (XY20) was chosen in order to reach the same tissue
concentrationas theXY2000group, allowingus to test if the
XY2000 treatment was active before 10 dpf. EE2 tissue
concentration of XY20 was 3.5-fold higher than in XY2000
(3975 995 and 1146 153 ng g1 respectively) at 10 dpf
following treatment (Fig. 2B). One day after the treatment,
however, theEE2 level of XY20 dropped to 397 39 ng g1
and continued to decrease faster than in XY2000 individu-
als. At 14 dpf, the values of EE2 concentration in XY2000
(28 12 ng g1) and XY20 (10 5 ng g1) were not signifi-
cantly different, although they remained significantly higher
Figure 1. Mean growth curves of tilapia progeny during the experimental period in (A) XY (n¼5) until 35 dpf and (B) YY (n¼4) until 42 dpf. XYC,
XY control group; XY2000, XY batch that underwent an EE2 immersion treatment (2000mgL1) for 4 hr at 1 dpf; XY20, XY batch immersed in
EE2 at 20mgL1 for 4 hr at 10 dpf; YYC, YY control group. YY6500, YY batch immersed in EE2 at 6500mgL1 for 4 hr at 1 dpf; YYD, YY submitted
to an EE2 dietary treatment of 500mgkg1 food from 1040 dpf. *P<0.05.
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than the controls. As in XY2000, the hormone level in XY20
returned to a basal level close to 0 ng g1 and was statisti-
cally similar to the controls at 21 dpf (0.55 0.67 ng g1).
InYY feminization experiments at a high concentration of
6500mgL1 (YY6500), EE2 uptake and clearance followed
the same profile as in XY2000, with a 10-fold bioconcentra-
tionof thehormone in the tissue immediatelyafter immersion
(Fig. 2C) and a maximum mean concentration of
62755 3691ngg1. EE2 level decreased thereafter to
6703 1789ngg1 at 10 dpf. At 14 dpf, the concentration
in YY6500 (28 7ngg1) was equal to that measured in
XY2000, and returned to a level (0.26 0.03 ngg1) statisti-
cally similar to the control at 21 dpf (Fig. 2D). In the dietary
EE2 groups (YYD) given a dose of 500mgEE2 kg1 in their
food from 1040 dpf, the EE2 tissue concentration slowly
increased to166 44ngg1at14dpf, 442 40ngg1 at21
dpf, and reached a maximum of 1792 295ngg1 at the
endof the treatment period (40dpf) (Fig. 2D). As soonas the
hormonal treatment ended, the concentration decreased
rapidly to 139 21ngg1 at 42 dpf.





(except forT inYY): 58 5ngTg1 and45 11ngE2g1 in
XYC; 37 9ng Tg1 and 67 6ng E2g1 in YYC. After 1
dpf, concentrations of T and E2 decreased until 1014 dpf,
TABLE 1. Survival Rates in 5 XY (35 dpf; P1 to P5) and 4 YY (42 dpf; P6 to P9) Progeny, and Sex-Ratios (% Females) at 90 dpf for
Tilapias Submitted to EE2 Feminization Treatments
XYC XY2000 XY20 YYC YY6500 YYD
Survival (%) 24.5 3.5a 27.73.2ab 40.64.6b 48.7 4.4a 37.9 4.7a 66.54.5b
% females (n sexed) P1 0.0a (53) 11.8b (68) 0.0a (66) P6 0.0a (103) 0.9a (106) 99.1b (113)
P2 0.0a (125) 60.6c (109) 8.6b (93) P7 0.0a (100) 0.8a (124) 100.0b (100)
P3 0.0a (110) 6.3b (111) 0.0a (101) P8 0.0a (100) 0.0a (118) 99.0b (100)
P4 0.0a (106) 0.9a (106) 0.0a (104) P9 0.0a (103) 0.0a (58) 83.7b (92)
P5 0.0a (100) 23.0c (100) 4.0b (101)
Mean 0.00.0a 20.5 10.7c 2.51.7b Mean 0.00.0a 0.40.3a 95.53.9b
XYC, XY control group; XY2000, XY submitted to an EE2 immersion treatment (2000mg L1) for 4 hr at 1 dpf; XY20, XY immersed in EE2 at 20mgL1 for 4 hr at 10 dpf;
YYC, YY control group; YY6500, YY immersed in EE2 at 6500mg L1 for 4 hr at 1 dpf; YYD, YY submitted to an EE2 dietary treatment of 500mg kg1 food from 1040
dpf. Different superscript letters (a, b, or c) indicate significant differences (P< 0.05).
Figure 2. Mean 17a-ethynylestradiol (EE2) tissue concentration in (A, B) XY (n¼5 progenies) and (C, D) YY (n¼4) progeny of Nile tilapia
submitted to feminization treatments. A and C: complete profiles;B and D: data between 0 and 5000ngg1. XYC, XY control group; XY2000, XY
submitted to anEE2 immersion treatment (2000mgL1) for 4 hr at 1 dpf; XY20, XY immersed in EE2 at 20mgL1 for 4 hr at 10 dpf. YYC, YY control
group; YY6500, YY immersed in EE2 at 6500mgL1 for 4 hr at 1 dpf; YYD, YY submitted to an EE2 dietary treatment of 500mgkg1 food from
1040 dpf.
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and remained at a low level (between 5 and 15ngg1) until
the end of the experimental period.
ForbothXYandYYgroups, individuals that receivedEE2
immersion treatment at1dpf (XY2000andYY6500)showed
a significantly increased level of T and E2 at 4 dpf compared
to controls (Fig. 3AD). No other significant differences
were observed between controls and immersion-treated
groups. E2 concentrations significantly increased in dietary
EE2-treated YY progeny at 35 and 40 dpf (Fig. 3D).
Theprofileof11-ketotestosterone(11KT)wasdifferent than
T or E2. In XY individuals (Fig. 3E), mean levels of 11KTwere
low and constant from 035 dpf and did not exceed 7ngg1.
YY eggs, however, contained a higher concentration of 11KT
at 0dpf (19 3ngg1) (Fig. 3F), but decreased thereafter until
10 dpf, settling at a similar level to the XY group. No significant
difference was observed in 11KT levels between control and
treated groups among any of the genotypes.
Overall, no correlation was observed between steroid
levels in eggs at 0 dpf and sex reversal rates.
Expression Analysis of Sex-Differentiating Genes
Early feminization treatments caused a strong and sig-
nificant increase in cyp19a1b expression in the heads of
tilapia embryos three days after the treatment (at 4 dpf)
(Fig. 4A and B). In the XY2000 EE2-treated group, we
observed a 2.4-fold change in the relative expression of this
gene (39.1 2.7%) compared to XYC controls
(16.1 1.2%) (Fig. 4A). Brain aromatase expression was
even higher in immersion-treated YY progeny (Fig. 4B),
with a 3.5-fold increase in relative expression seen in
the YY6500 (64.7 5.6%) compared to YYC controls
(18.4 1.3%). No significant difference was observed be-
tween XY and YY controls. On the other hand, 4 dpf
expression levels of amh and foxl2 were very low (Fig.
4A and B), and were not affected by the hormonal immer-
sion treatments or by the genotype (P> 0.05).
None of the three analyzed genes showed a signifi-
cant difference in expression levels between control and
EE2-treated groups or between genotypes in the heads
of 14 dpf fry (Fig. 4C and D). Compared to 4 dpf, the
relative expression of cyp19a1b was lower in all the
groups (XYC, 10.2 1.6%; XY2000, 11.9 3.7%;
YYC, 7 1.3%; YY6500, 13.2 2.4%). Both amh and
foxl2 expressions, however, were up-regulated at this
age. From 414 dpf, amh expression increased from
1.0 0.516.2 2.3%; from 0.5 0.212.9 3.1%;
from 1.1 0.330.4 15.6%; and from 1.7 0.4
Figure 3. A, B: Mean testosterone (T), C, D: 17b-estradiol (E2), and E, F: 11-ketotestosterone tissue concentration in XY (n¼5) and YY (n¼4)
progenies of Nile tilapia submitted to feminization treatments. XYC, XY control group; XY2000, XY submitted to an EE2 immersion treatment
(2000mgL1) for 4 hr at 1 dpf; XY20, XY immersed in EE2 at 20mg L1 for 4 hr at 10 dpf. YYC, YY control group; YY6500, YY immersed in EE2 at
6500mg L1 for 4 hr at 1 dpf; YYD, YY submitted to an EE2 dietary treatment of 500mgkg1 food from 1040 dpf. *P<0.05.
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23.4 4.4% in XYC; XY2000 YYC; and YY6500 groups,
respectively. Foxl2 expression increased from
2.0 0.333.4 10.7%; from 1.0 0.335.0 14.3%;
from 3.5 1.734.5 25.5%; and from 1.2 0.6
26.8 8.5% in XYC; XY2000 YYC; and YY6500 groups,
respectively.
No correlation was observed between changes in gene
expression levels in control versus treated groups and sex
reversal rates.
DISCUSSION
A 4 hr-immersion treatment in 2000mg EE2L1 at 1 dpf
induced up to 60% feminization in XY fish, confirming the
existenceof anearly sensitiveperiod for sex reversal during
sex determination in the Nile tilapia. To our knowledge, this
is the first time that early hormonal treatment was shown to
induce sex reversal in tilapia. Similar feminizing treatments
were performed on O. mossambicus embryos by Rose-
nstein and Hulata (1992), but failed to induce a sex-
reversed phenotype. Our first work (Rougeot et al.,
2008a) reported that immersion treatment in 100500mg
EE2L1 from 12 hpf to 5 dpf induced 5568% sex reversal
in XY individuals, but the duration of the treatment and
the consequent persistence of exogenous estrogen in the
developing fry (more than 5000 ng g1 at 10 dpf; unpub-
lished data) left some uncertainty about the actual period of
exogenous estrogen activity. Here, we shortened the treat-
ment period and used a higher EE2 concentration in order
to focus on treating during the embryonic stage, thereby
avoiding a delayed effect due to the accumulation of hor-
mone after 10 dpf. As demonstrated by the low deviation in
sex ratio induced by treating individuals at 10 dpf, residual
hormone from the early treatment at 1 dpf could not be
responsible for the observed sex-reversed effect; the sex
reversal phenotype is more likely caused by a mechanism
operating before 10 dpf.
Complete sex reversal of O. niloticus XY fry, via an
immersion treatment at the onset of gonad differentiation,
was also achieved by Kobayashi et al. (2003) using similar
or higher EE2 concentrations than we did (from 101000
mgL1) for a period of 3 days (from 810 dpf). An inverse
relationship between dose and treatment duration has
been reported for sex reversal (Piferrer, 2001), so it is likely
that obtaining 60% sex reversal requires a higher estrogen
intakeat 10dpf than the residual concentrationmeasured in
individuals treated at 1 dpf. The increase in T and E2
concentrations and the up-regulation of cyp19a1b expres-
sion induced by the early treatment were observed at 4 dpf
but was not sustained by 14 dpf, suggesting that hormonal
treatment acted only briefly on these parameters. The
Figure 4. Mean relative expression of cyp19a1b, amh, and foxl2 at 4 dpf (A,B) and 14 dpf (C,D) in heads of XY (n¼5) and YY (n¼4) progeny of
Nile tilapia submitted to early-feminization treatment. XYC, XY control group; XY2000, XY submitted to an EE2 immersion treatment (2000mg L1)
for 4 hr at 1 dpf; XY20, XY immersed in EE2 at 20mgL1 for 4 hr at 10 dpf. YYC, YY control group; YY6500, YY immersed in EE2 at 6500mgL1 for
4 hr at 1 dpf; YYD, YY submitted to an EE2 dietary treatment of 500mgkg1 food from 1040 dpf. *P<0.05.
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hormone-sensitive period of sex determination in embryos
corresponds to the early thermo-sensitive period for mas-
culinization that was determined by Rougeot et al. (2008b).
As temperature likely does not act through accumulation or
provide a substantial delayed effect, these two studies are
consistent with the existence of an embryonic sensitive
period during which sex can be reversed in Nile tilapia.
A brief hormone exposure avoided the drawback of
reduced survival rates induced in thermal treatments (Rou-
geot et al., 2008b; Wessels et al., 2011) or by longer
exposures (Rosenstein and Hulata, 1992; Rougeot et al.,
2008a).Survival-ratevalues,however,have tobecautiously
interpreted from this study; these rates were likely under-
estimated due to the timed sampling process, which intro-
duced an important bias that more severely affected groups
inwhich thenumber sampled representsahighproportionof
the total number of fish (XY2000, XYC, YY6500, and YYC
groups). Given the similar survival rates estimated in XYC
and XY2000, on the one hand, and in YYC and YY6500, on
the other hand, plus the low mortality observed during the
experimental period, we can conclude that brief (4 hr) expo-
sure of tilapia embryos to EE2 (up to 6500mgL1) does not
affect their survival. Short immersions alsodid not adversely
affect growth during the experimental period. This result
contrasts with the impaired growth reported by Shved et al.
(2008) following long-term exposure (from 10100 dpf) of
XY tilapia to environmentally relevant EE2 concentrations
(525ngL1). Growth was also reduced in dietary EE2-
treated XY tilapia (at 125mgkg1 food) from 90 dpf, that is,
50 days after the end of the treatment (Shved et al., 2007);
we similarly observed a 50% growth reduction in YY fry fed
with an EE2-supplemented diet (500mgkg1 food) at the
end of the treatment (42 dpf). This early decrease in growth
might be attributed to a toxic effect of EE2 that arises with
higher doses.
Early sex reversal in embryos by brief hormonal expo-
sure was also observed in medaka (Kobayashi and Iwa-
matsu, 2005; Iwamatsu et al., 2005; 2006a). As medaka
and Nile tilapia undergo similar morphogenesis during sex
differentiation (Siegfried, 2010) and both present an early,
sensitive sex-determining period long before gonadal dif-
ferentiation, these two species are interesting models of
gonochoristic teleosts for studying upstream sex-determin-
ing mechanisms. Unlike in medaka, however, nomajor sex
determinant that is similar to themedaka dmy gene nor the
involvement of primordial-germ-cell proliferation or their
surrounding cells in the mechanism of early sex reversal
(Kobayashi et al., 2004) has yet been defined in the Nile
tilapia (Cnaani et al., 2008; Palaiokostas et al., 2013). On
the other hand, Rougeot et al. (2008a) proposed and
D’Cotta et al. (2001) provided evidence for a role of the
brain in the sex-differentiation cascade. To explore this
paradigm, we searched for sex-differentiating genes differ-
entially expressed in the head of estrogen-immersed
embryos.
Early estrogen treatments affected brain differentiation,
as cyp19a1b was clearly up-regulated at 4 dpf in those
embryo heads exposed toEE2.Cyp19a1b is very sensitive
to exogenous estrogens due to the presence of a con-
served estrogen responsive element in its promoter (Diotel
et al., 2010). Estrogens and high aromatase activity are
recognized to play an important role in neurogenesis,
although their role in brain sexual differentiation is still
unclear (Le Page et al., 2010). Cyp19a1b is expressed
in the brain early in development in different species, with a
clear sexually dimorphic expression before the onset of
gonadmorphological differentiation reported in the rainbow
trout (Vizziano-Cantonnet et al., 2011). In the pejerrey,
cyp19a1bwas not differentially expressed before the onset
of sex differentiation at either female- or male-promoting
temperatures; in adults, however, E2 treatments caused
cyp19a1b up-regulation together with the estrogen recep-
tors era and erb (Strobl-Mazzulla et al., 2008). No sex
differences for cyp19a1b were found during development
in medaka, although higher levels were observed in adult
females (Okubo et al., 2011). In the Nile tilapia, the expres-
sion of the two genes coding for aromatase is initiated in
embryos at 34 dpf (Kwon et al., 2001). During gonad
differentiation, high expression level of the ovarian form of
cyp19a1b (from 9 dph) is found in female gonads (D’Cotta
et al., 2001; Ijiri et al., 2008) while the brain form is ex-
pressed at the same level in XX and XY brains (Kwon et al.,
2001), suggesting that in tilapia it plays a role in neuro-
genesis rather than in sexual differentiation.
Temperature-dependent sex reversal is accompanied
by a decrease in brain aromatase activity during the sex-
differentiatingperiod (D’Cotta et al., 2001),with higher brain
aromatase activity in XX females than in XY males under
normal thermal conditions. This observation, together with
our results, suggest that a role for the brain and particularly
for brain aromatase in gonad sex differentiation cannot be
ruled out, and that post-transcriptional control could be
responsible for regulating sex-specific aromatase activity
(Balthazart et al., 2011). In tilapia, sex-specific expression
of cyp19a1b may be restricted to certain nuclei and not be
readily observable. Comparison between XY and YY gen-
otypes showed that this increase in gene expression was
dependent on EE2 dose, and was also associated with an
increase in both T and E2 concentrations. While the in-
crease inE2 synthesiswas probably a result of the elevated
cyp19a1b levels induced by exogenous EE2, the increase
in T suggests that estrogen treatment also up-regulated the
expression or activity of other steroidogenic enzymes long
before the gonad is formed.Despite these associations, the
up-regulation of cyp19a1b in treated embryos cannot be
entirely responsible for the sex-reversal effect seen in the
present study as no sex reversal was observed in YY
progeny. If the brain is involved in the mechanism of early
sex reversal, and consequently in early sex determination,
this mechanism should be more complex and mostly likely
require additional factors beyond aromatase.
To investigate one of thepossible regulators of cyp19a1b
expression,wemeasured theearlyexpressionof foxl2 in the
brain of normal and sex-reversedXYandYY tilapias. Trans-
activation studies have shown that the transcription factor
foxl2, together with steroidogenic factor 1 (sf1), can activate
the transcription of cyp19a1a by binding to its promoter
(Wang et al., 2007). In tilapia gonads, foxl2 is co-expressed
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at the initiation of the ovarian differentiation, suggesting that
it regulates in vivo cyp19a1a expression (Wang et al., 2007;
Ijiri et al., 2008)although temporal co-expression was not
evident in other tilapia strains and temperature-induced
masculinization did not suppress expression of both genes
simultaneously (Poonlaphdecha et al., 2013). Our present
results also suggest that brain-expressed foxl2 does not
regulate cyp19a1b expression, and does not participate in
early sex reversal. We found very low or no expression of
foxl2 in the embryonic head of XY controls and in EE2-
treated embryos, whereas cyp19a1b was markedly and
differentially expressed between the two groups. As foxl2
expression is strongly induced by estrogens in the gonad
(Baronet al., 2004;Wanget al., 2007), wepostulate that this
genewas totally repressed or not yet transcribed in the brain
of tilapia embryos at the stage analyzed as foxl2 was ex-
pressed during gonad differentiation on 14 dpf at a similar
level in both XY and YY fish and those treated with EE2.
Consistent with our findings, foxl2 is not the only trigger
regulating cyp19a1b in the brain in rainbow trout (Vizziano-
Cantonnet et al., 2011), and a cooperative regulation of
cyp19a1b by foxl2 and the nuclear receptor ftz-f1 has
been demonstrated in Clarias gariepinus (Sridevi et al.,
2012). More investigations are needed to understand the
role of foxl2 in the brain of teleosts.
Amh was another candidate cerebral genetic factor that
could be involved in early sexual reversal. In different
species, amh and cyp19a1a have reciprocal expression
profiles in the differentiating gonad (Wang andOrban 2007;
Fernandino et al., 2008). In Nile tilapia, Poonlaphdecha
et al. (2013) suggested that cyp19a1a inhibits amh expres-
sion in the gonads of genetic females. Amh is down-regu-
lated by estrogens (Schulz et al., 2007; Fernandino et al.,
2008) in the gonad, and sexually dimorphic expression
levels are observed between genetic males and females
in the tilapia brain at 14 dpf (Poonlaphdecha et al., 2011). In
our study, amh expression was totally repressed in embry-
os independent of EE2 exposure. As observed for foxl2,
amh expression was initiated later in the brain and showed
no difference between controls and EE2 sex-reversed fish.
This suggests that the expression level of amh could be
related to the sex genotype, and that a factor linked to the Y
chromosome may control its expression regardless of the
sex phenotype.
The sensitivity of XY progeny to EE2 treatments varied
widely among individuals, as demonstrated by the sex-
reversal rates ranging from 060%. This variability could
be related to the differential expression of sex-determining
genes or to the endogenous steroid balance during onto-
genesis and maternal steroid inheritance. In tilapia, estro-
gens are required for ovarian differentiation (Kobayashi
et al., 2003; Nakamura, 2010) and are also involved in
neurogenesis and brain sexualization, as suggested by the
early expression of brain aromatase (Diotel et al., 2010; Le
Page et al., 2010). Steroid metabolism is initiated early in
embryogenesis as maternal hormones are metabolized
during the first days of development (Hines et al., 1999).
We therefore hypothesize that the steroid content of freshly
fertilized eggs ismaternally inherited andmay influence the
sex-determining mechanism. Yet, we did not find a corre-
lation between steroid content (T, E2, and 11KT) in freshly
ovulated eggs and sex-reversal rates. Deviation from a 1:1
sex ratio in normal crosses (Lester et al., 1989) and herita-
ble differences in temperature-related sex influences (Bar-
oiller et al., 2009; Wessels and H€orstgen-Schwark, 2011)
demonstrate that sex determination is multifactorial in tila-
pia; we suggest that such factors could further influence the
responsiveness to early hormonal treatment.
If egg steroid content is not a determinant of sexual
development, we postulate that a genetic determinant
present on the sex chromosomes is responsible for the
absence of early sex reversal in YY. For example, there
could be a feminizing factor linked to the X chromosome
that is necessary to elicit a response to the estrogen
treatment, or alternatively a masculinizing factor linked to
the Y chromosome wherein the presence of two copies
represses or disables any feminizing effect of the exoge-
nous hormone. The absence of sex reversal in YY is
nevertheless a striking and very interesting result as it
suggests that an upstream genetic determinant linked to
the sex chromosomes can influence sex determination in
the first days of the embryogenesis, long before the earliest
known evidence of a gonadal differential gene expression
(9 dph) (Ijiri et al., 2008).
In summary, we demonstrated for the first time that brief
EE2 treatments during embryogenesis are effective in
reversing XY tilapias towards a female phenotype,
highlighting the existence of an early sensitive period for
sex reversal during tilapia sex determination encompass-
ing embryonic and larval development, prior to any sign of
gonad differentiation. This early-embryo induced feminiza-
tion was ineffective in YY fish, suggesting that a Y-linked
repressor may be modulator or alternatively that an activa-
tor on the X chromosomemight be needed. Our embryonic
feminizing procedure thus constitutes a new tool for identi-
fying major, upstream sex determinants in the Nile tilapia.
MATERIAL AND METHODS
Fish Stock Housing, Reproduction, and Juvenile
Rearing
Nile tilapia O. niloticus of the Lake Manzala strain were
from the Research and Education Center in Aquaculture
(CEFRA), University of Liege, Belgium. All-male XY prog-
eny were obtained by artificial reproduction of YY males
with XX females, and supermale YY progenies from YY
males mated with YY females, as described in Gennotte
et al. (2012).
After artificial fertilization, eggs were weighed and
counted. Each progeny was divided into three batches
(for the XY group: controls, a 4-hr-treated group at 1 dpf,
and a 10 dpf-treated group; for the YY group: controls, a 4-
hr-treated group at 1 dpf, and a 30-day diet-treated group)
and incubated in 1.5 L Zug bottles at 27 8C. Fertilization
rates were evaluated on 100 eggs after the first mitotic
cleavage (2 hpf) (Morrison et al., 2001). Hatching rates
were assessed by counting all fish fromeach batch at 4 dpf.
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Larvae were transferred at 8 dpf into 50-L aquaria (mean
stocking density standard deviation of 5.4 1.7 fish L1)
and feeding started at 10 dpf. In order to determine the food
ratio and follow the growth and survival of each batch, the
number of individuals and total biomass were recorded
every week from 8 dpf to 35 dpf (XY) or 42 (YY) dpf.
Homogenization of fish growth between treated and control
groups, and among progeny, was essential to standardize
the developmental speedand the post-treatment kinetics of
EE2 clearance. Fish were fed close to satiation, and food
ratios were adjusted to assure the same growth in all
batches. Food distribution was performed six times a day
with a commercial tilapia diet (47% proteins, 8% lipids)
(Coppens, The Netherlands). Experiments were carried
out according to the guidelines of the University of Liege
ethical committee and the European animal welfare
recommendations.
17a-Ethynylestradiol Solutions
17a-ethynylestradiol (SigmaAldrich, Saint-Louis, MO,
US)was dissolved in 100%ethanol, and then stored at 48C.
Stock solutions were prepared at different concentrations:
20, 2000, and 6500mgL1. For each experiment, 1ml of
stock solution was added to 1 L of water. Control groups
were incubated in a 1:1000-diluted ethanol solution. For the
YY feminization group treated with EE2-supplemented
feed, 500mg of EE2 was dissolved in 600ml of 95%
ethanol, and mixed with 1 kg of food pellets. It was then
allowed to dry and stored at 48C.
Early Feminization of XY Individuals
To test thesex-inversionefficiencyofhormonal treatment
on developing embryos, feminization treatments were ap-
plied to one of the five XY progeny batches. The treatment
consisted of a single 4hr immersion in a 2000mg EE2 L1
solution (XY2000 group) at 1 dpf, and was conducted by
transferring the eggs from the Zug bottle into a 1L glass
beaker filled with hatchery water and maintained in a ther-
mostaticbathat278C.Onemilliliterof stocksolution (ethanol
for control groups) was then added to the water. During
incubation, thewaterwasoxygenatedbyanairdiffuser.After
4 hr of immersion, the eggs were netted, the solution gently
removed by soaking on paper, and the eggs were rinsed in
six different baths to remove hormone residues. The first
threebaths contained1:1000ethanol and thenext threehad
only hatchery water. The batches corresponding to control
groups (XYC) were handled in the same way. After rinsing,
eggs were returned to the hatchery.
In order to verify that the 1 dpf feminization treatment
targeted the early developmental stages before 10 days
rather than by tissue accumulation of the hormone followed
by a delayed effect after 10 dpf, we treated the third batch of
eachprogenyat 10dpfwith a 4-hr immersion in a20mgEE2
L1 solution (XY20 group). This lower dose was used to
reach an EE2 tissue concentration similar to the residual
concentrationmeasured in theXY2000groupat 10dpf. The
immersion procedure was essentially the same as the egg
treatment.
For steroid analysis, individuals were sampled in XYC,
XY2000, and XY20 groups at 0 (unfertilized eggs, n¼ 67
100), 1 (n¼ 80100), 4 (n¼ 70100), 10 (n¼ 4060), 11
(n¼ 2040), 14 (n¼ 1530), 21 (n¼ 610), 28 (n¼ 6
10), and 35 (n¼ 610) dpf. Samples were weighed
and stored at 808C until needed for steroid extraction.
Gene expression analysis was performed on individuals
sampled at 4 (n¼ 50) and 14 (n¼ 2050) dpf in control and
XY2000 groups. Samples were preserved in RNA Later
(Ambion, Austin, TX, US) at 208C following the manu-
facturer’s instructions, before RNA extraction.
Early Feminization of YY Individuals
FourYYprogenybatcheswereproducedanddivided into
three. The treated batches were immersed for 4 hr in a
6500mg EE2L1 solution at 1 dpf (YY6500), following the
same protocol as described above for the XY-treated eggs.
Preliminaryresults(unpublished)showedthattreatmentwith
a2000mgEE2L1 solutionhadnoeffect onYYsexreversal,
sowe increased theEE2 concentration for theYY treatment
in proportion to the EE2 concentrations used in the dietary-
hormonetreatment (150mgkg1 forXYand500mgkg1 for
YY) (unpublished data). Control batches (YYC) were im-
mersed in a solution containing only ethanol (1:1000). The
third group (YYD) was fed dietary hormone, and this batch
served as a positive control for sex reversal. The fry from the
YYDbatchwere fedaEE2-supplementeddiet (500mgkg1
food) ad libitum from 1040 dpf to verify the susceptibility of
eachprogenytothefeminizationtreatmentappliedduringthe
known sensitive period of sex differentiation.
Samplings for steroid analysis were carried out in
YYC, YY6500, and YYD at 0 (unfertilized eggs, n¼ 100),
1 (n¼ 80100), 4 (n¼ 65150), 10 (n¼ 30100),
14 (n¼ 1560), 21 (n¼ 615), 28 (n¼ 610), 35 (n¼ 6
10), 40 (n¼ 610), and 42 (n¼ 610) dpf. Samples were
weighed and stored at 808C until needed for steroid
extraction.
Gene-expression analysiswas performed on individuals
sampled at 4 (n¼ 4050) and 14 (n¼ 2050) dpf in control
andYY6500groups.Sampleswerepreserved inRNALater
(Ambion) at 208C, following the manufacturer’s instruc-
tions, before RNA extraction.
Sex-Ratio Analysis
Phenotypic sex was determined by the acetocarmine
squash method (Guerrero and Shelton, 1974) at 90 dpf.
Fish were euthanized by an overdose (500mgL1) of
benzocaine (SigmaAldrich), and a slice of the gonads
from 53125 fish per batch was microscopically examined
after acetocarmine coloration.
Steroid Extraction
Steroids were extracted from homogenized samples
(0.251.15 g weight) following a procedure described
inD’Cotta et al. (2001). After threeextractionswith dichloro-
methane, extracts were suspended in 300ml of 100%
ethanol and stored at 208C until needed for assessment.
Molecular Reproduction & Development GENNOTTE ET AL.
1154 Mol. Reprod. Dev. 81:1146–1158 (2014)
EE2 Enzyme Immunoassay
EE2 was assayed by enzyme-linked immunosorbent
assay following the manufacturer’s instructions (Europrox-
ima, The Netherlands). Twenty microliters of extract were
dissolved in 180ml of dilution buffer provided with the kit.
Each sample from treated groups was further diluted to
reach a concentration in the detection range (0.022 ng
g1) of the kit. All samples were assayed in duplicate.
Testosterone, 17b-Estradiol, and 11-
Ketotestosterone Radioimmunoassays
Testosterone (T), 17b-estradiol (E2), and 11-ketotestos-
terone (11KT) concentrations were assayed in developing
eggs, larvae, and juveniles by radioimmunoassay, as de-
scribed inDouxfils et al. (2007).Radioactivehormoneswere
purchased from Amersham Pharmacia (Buckingamshire,
England). T and E2 antibodies were obtained from the
Laboratoire d’Hormonologie de Marloie (CER, Belgium),
and the anti-11KTwas a gift fromA. Fostier (INRA, Rennes,
France). Detection limits ranged from 5080pgml1.
Total RNA Extraction and Reverse Transcription
Heads were dissected from their trunks under a ste-
reomicroscope, and placed in RNA Later. Each batch
sampled was divided into two or three replicates, and
each replicate contained from 617 heads. Total RNA
was extracted from pooled heads using TRIzol reagent
(Invitrogen, Carlsbad, CA, US), following the manufac-
turer’s protocol, after which total RNA was resuspended in
30150ml of RNase-free water and quantified with a
NanoDrop (Thermo Scientific, Wilmington, DE, US). Ex-
tracts were treated to remove genomic DNA with TURBO
DNase (Ambion), and single-strand cDNA was produced
using SuperScript II reverse transcriptase (Invitrogen), as
described in Poonlaphdecha et al. (2011). Reverse tran-
scription was performed with 5 and 4mg of total RNA for
samples from 4 and 14 dpf, respectively. The cDNA was
diluted in water to 25 ngml1 and stored at 208C for
quantitative real-time PCR.
Quantitative Real-Time PCR Analysis
Expression levels of cyp19a1b, amh, and foxl2 were
studied in embryo (4 dpf) and fry heads (14 dpf). Quantita-
tive PCR was performed on a MX3000P (cyp19a1b and
amh) or MX3005P (foxl2) real-time PCR system (Strata-
gene, La Jolla, CA, US). Due to its expression stability
during estrogen exposure (data not published), ef1a was
used as a reference to standardize gene expression levels.
The primers used are listed in Table 2. All biological rep-
licates were analyzed in duplicate from 10ml reactions
using Brilliant II SYBR1 Green QPCR Master Mix (Agilent
Technologies, Santa Clara, CA, US). Reactions were run
with 50 ng cDNA and a concentration of 300 nM for each
primer. PCR cycling parameters, control of reaction speci-
ficity, and calculation method for gene expression levels
(expressed asmean normalized expression) are described
in Poonlaphdecha et al. (2011, 2013).
Data Analysis
Data are reported as mean standard error of the mean.
Mean values of growth, steroid concentrations, and relative
gene expressions were compared between groups (treated
versus control). Normality was analyzed with the Shapir-
oWilk test, and homoscedasticity with the Levene test. If
data compliedwith these twoconditions, differencesbetween
meanswere searched byANOVA, andmultiple comparisons
were performed with the Fisher’s LSD test. Otherwise, non-
parametric KruskalWallis test and MannWhitney test
wereused.Thechi-squared testwasused toanalyzesurvival
and sex reversal rates. Spearman rank correlation coeffi-
cientswereused to identify correlationsbetweensex reversal
rates, steroid concentrations in unfertilized eggs, and
changes in gene expression levels. Differenceswere consid-
ered as significant at P< 0.05. Statistical analysis was per-
formed using Statistica v.10 (StatSoft, France).
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